Return On Equity of Cyclo Therapeutics, Inc. from 30 Sep 2013 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cyclo Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2013 to 30 Sep 2024.
  • Cyclo Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2024 was 750%, a 78% decline year-over-year.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2023 was -4506%, a 2024% decline from 2022.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2022 was -212%, a 1.7% increase from 2021.
  • Cyclo Therapeutics, Inc. annual Return On Equity for 2021 was -216%, a 62% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Cyclo Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 750% -2711% -78% 01 Jul 2024 30 Sep 2024
Q2 2024 10261% +11968% 01 Apr 2024 30 Jun 2024
Q1 2024 -2742% -2289% -506% 01 Jan 2024 31 Mar 2024
Q4 2023 -4506% -4294% -2024% 01 Oct 2023 31 Dec 2023
Q3 2023 3461% +3581% 01 Jul 2023 30 Sep 2023
Q2 2023 -1707% -1595% -1427% 01 Apr 2023 30 Jun 2023
Q1 2023 -452% -246% -119% 01 Jan 2023 31 Mar 2023
Q4 2022 -212% +4% +1.7% 01 Oct 2022 31 Dec 2022
Q3 2022 -120% +146% +55% 01 Jul 2022 30 Sep 2022
Q2 2022 -112% +246% +69% 01 Apr 2022 30 Jun 2022
Q1 2022 -207% -21% -11% 01 Jan 2022 31 Mar 2022
Q4 2021 -216% +351% +62% 01 Oct 2021 31 Dec 2021
Q3 2021 -266% -1376% -124% 01 Jul 2021 30 Sep 2021
Q2 2021 -358% +4179% +92% 01 Apr 2021 30 Jun 2021
Q1 2021 -185% +252% +58% 01 Jan 2021 31 Mar 2021
Q4 2020 -567% -211% -59% 01 Oct 2020 31 Dec 2020
Q3 2020 1110% +1403% 01 Jul 2020 30 Sep 2020
Q2 2020 -4537% -4125% -1001% 01 Apr 2020 30 Jun 2020
Q1 2020 -437% +1058% +71% 01 Jan 2020 31 Mar 2020
Q4 2019 -355% +313% +47% 01 Oct 2019 31 Dec 2019
Q3 2019 -294% +340% +54% 01 Jul 2019 30 Sep 2019
Q2 2019 -412% +56% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -1495% -1142% -324% 01 Jan 2019 31 Mar 2019
Q4 2018 -669% -424% -174% 01 Oct 2018 31 Dec 2018
Q3 2018 -634% -436% -221% 01 Jul 2018 30 Sep 2018
Q2 2018 -468% -254% -119% 01 Apr 2018 30 Jun 2018
Q1 2018 -353% -176% -100% 01 Jan 2018 31 Mar 2018
Q4 2017 -245% -88% -56% 01 Oct 2017 31 Dec 2017
Q3 2017 -197% -60% -44% 01 Jul 2017 30 Sep 2017
Q2 2017 -214% -121% -131% 01 Apr 2017 30 Jun 2017
Q1 2017 -177% -102% -135% 01 Jan 2017 31 Mar 2017
Q4 2016 -157% -94% -149% 01 Oct 2016 31 Dec 2016
Q3 2016 -137% -94% -217% 01 Jul 2016 30 Sep 2016
Q2 2016 -93% -62% -200% 01 Apr 2016 30 Jun 2016
Q1 2016 -75% -49% -182% 01 Jan 2016 31 Mar 2016
Q4 2015 -63% -47% -285% 01 Oct 2015 31 Dec 2015
Q3 2015 -43% -31% -257% 01 Jul 2015 30 Sep 2015
Q2 2015 -31% -21% -204% 01 Apr 2015 30 Jun 2015
Q1 2015 -27% -36% -393% 01 Jan 2015 31 Mar 2015
Q4 2014 -16% -28% -245% 01 Oct 2014 31 Dec 2014
Q3 2014 -12% -36% -151% 01 Jul 2014 30 Sep 2014
Q2 2014 -10% 01 Apr 2014 30 Jun 2014
Q1 2014 9% 01 Jan 2014 31 Mar 2014
Q4 2013 11% 01 Oct 2013 31 Dec 2013
Q3 2013 24% 01 Jul 2013 30 Sep 2013

Cyclo Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -4506% -4294% -2024% 01 Jan 2023 31 Dec 2023
2022 -212% +4% +1.7% 01 Jan 2022 31 Dec 2022
2021 -216% +351% +62% 01 Jan 2021 31 Dec 2021
2020 -567% -211% -59% 01 Jan 2020 31 Dec 2020
2019 -355% +313% +47% 01 Jan 2019 31 Dec 2019
2018 -669% -424% -174% 01 Jan 2018 31 Dec 2018
2017 -245% -88% -56% 01 Jan 2017 31 Dec 2017
2016 -157% -94% -149% 01 Jan 2016 31 Dec 2016
2015 -63% -47% -285% 01 Jan 2015 31 Dec 2015
2014 -16% -28% -245% 01 Jan 2014 31 Dec 2014
2013 11% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.